Streptozocin

ATC Code L01AD04

Streptozocin

Definition

A methylnitrosourea antineoplastic antibiotic isolated from the bacterium Streptomyces achromogenes. Streptozocin alkylates DNA, forming inter-strand DNA cross-links and inhibiting DNA synthesis. Due to its glucose moiety, this agent is readily taken up by pancreatic beta cells, inducing diabetes mellitus at high concentrations. Unlike other nitrosoureas, streptozocin causes little myelosuppression. (NCI04)

Also known as 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose, 2-deoxy-2-[[(methylnitrosamino)-carbonyl]amino]-D-glucopyranose, STREPTOZOCIN, Streptozotocin, STZ, U 9889, U-9889, Zanosar — per NCIT

Also identified as

Indications

Disease Relation Source
Colorectal neoplasm may treat MEDRT · Public domain (U.S. Government work)
Hodgkins lymphoma may treat MEDRT · Public domain (U.S. Government work)
Pancreatic endocrine carcinoma may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Alimentary part of gastrointestinal system may treat a disease of this organ DERIVED · CC BY 4.0
Endocrine gland may treat a disease of this organ DERIVED · CC BY 4.0
Lymphoid system may treat a disease of this organ DERIVED · CC BY 4.0
Pancreas may treat a disease of this organ DERIVED · CC BY 4.0

4 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.